At the inaugural ACCC Leadership Summit, C-suite executives and senior-level decision makers in oncology convened for strategic dialogue, panel discussions, and peer-to-peer exchange focused on the most pressing issues in cancer care today. In this episode, CANCER BUZZ speaks with Jay Seemann, vice president of market and access value at BeOne Medicines, about his key takeaways as a member of the panel: Health Policy: Provider Voices Outlook. Seemann addresses macro-level health care reform changes across all market segments, and the impact on manufacturers, providers’ choice of therapy, and patient access to care.
“What we heard at the conference is that we all need to unite, come together, and come up with partnerships and solutions collectively versus independently.” – Jay Seemann
Guest:
Jay Seemann
Vice President of Market And Access
BeOne Medicines
Resources:
This podcast was made possible with support from BeOne Medicines.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
